KH, MB, and JB: funding acquisition
He says it's down to funding - to get a product from animal studies to human trials and to a fully licensed medicine takes years and billions of dollars
Gild ML, Stuart M, Clifton-Bligh RJ, Kinahan A, Handelsman DJ
The strength of this study is that it is the first clinical study to investigate the lipid-lowering effects of LC supplementation in CAD patients, and we measured the levels of LC, lipid profiles, and antioxidant enzyme activity
At first, this might seem like a downside after all, clinical research has reliably shown that less than 1% of all orally ingested berberine ends up circulating in the bloodstream40 but then you recognize that berberine studies typically do not use bioenhanced forms
Medications Requiring Precise Absorption Drugs with narrow therapeutic windows, such as anticoagulants and certain antiepileptics, are particularly sensitive